TERRELL JASON BRADLEY MD 4
4 · VOLITIONRX LTD · Filed Jul 1, 2019
Insider Transaction Report
Form 4
VOLITIONRX LTDVNRX
TERRELL JASON BRADLEY MD
Chief Medical Officer
Transactions
- Disposition to Issuer
Warrant (Right to Buy)
2019-07-01−125,000→ 0 totalExercise: $2.47→ Common Stock (125,000 underlying) - Award
Warrant (Right to Buy)
2019-07-01+125,000→ 125,000 totalExercise: $2.47→ Common Stock (125,000 underlying)
Footnotes (3)
- [F1]The two reported transactions involved an amendment of an outstanding warrant, resulting in the deemed cancellation of the "old" warrant and the grant of a "replacement" warrant. The replacement warrant amends the performance criteria for the remaining vesting milestones.
- [F2]The date exercisable is variable and depends on the achievement of the performance criteria outlined in the warrant agreement, as amended.
- [F3]The subject warrant shall expire three years after the vesting date.